Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) and thoracic radiotherapy are increasingly used to treat advanced cancers. Despite data indicating exaggerated radiation toxicities in patients with autoimmune disease, the safety of thoracic radiotherapy in patients with prior ICI-associated immune-re...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Oncol
Asıl Yazarlar: Shaverdian, N., Beattie, J., Thor, M., Offin, M., Shepherd, A. F., Gelblum, D. Y., Wu, A. J., Simone, C. B., Hellmann, M. D., Chaft, J. E., Rimner, A., Gomez, D. R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284745/
https://ncbi.nlm.nih.gov/pubmed/33010460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.annonc.2020.09.016
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller